Saltar al contenido
Merck

Saltar a

CAS9PROT

Cas9 Protein

from Streptococcus pyogenes, recombinant, expressed in E. coli, 1X NLS

Sinónimos:

Cas9, SpCas9, SpyCas9

para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
A ustedes/SKUDisponibilidadPrecio
50 μg
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
97,50 €
250 μg
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
325,00 €

Acerca de este artículo

NACRES:
NA.51
UNSPSC Code:
12352202
Form:
lyophilized powder
Assay:
≥95% (SDS-PAGE)
Recombinant:
expressed in E. coli

97,50 €


Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad

Solicita un pedido personalizado
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


recombinant

expressed in E. coli

Quality Segment

assay

≥95% (SDS-PAGE)

form

lyophilized powder

packaging

pkg of 1 kit (3 components)

application(s)

CRISPR

shipped in

wet ice

storage temp.

−20°C

General description

Recombinant Cas9 protein from Streptococcus pyogenes (~160 KD) is a ready-to-use reagent for genome engineering experiments. When combined with target-specific guide RNAs, wild type Streptococcus pyogenes Cas9 protein will act as a targeted nuclease suitable for transfection of cell cultures and for the accelerated development of genetically-modified animals via one-cell embryo injection.
CAS9, also known as cas5 and csn1, is the signature gene of the type II clustered regularly interspaced short palindromic repeats (CRISPR)-RuvC (RNase H-like fold) cas system. CAS9 contains 1388 amino acids. This protein is predicted to contain a RuvC/ ribonuclease (RNase) H domain involved in crRNA maturation and McrA/HNH signature domain involved in the DNA degradation step.

Application

Functional Genomics/Target Validation/Genome Editing

Biochem/physiol Actions

CRISPR/Cas systems are employed by bacteria and archaea as a defense against invading viruses and plasmids. Recently, the type II CRISPR/Cas system from the bacterium Streptococcus pyogenes has been engineered to function in eukaryotic systems using two molecular components: a single Cas9 protein and a non-coding guide RNA (gRNA). The Cas9 endonuclease can be programmed with a gRNA, directing a DNA double-strand break (DSB) at a desired genomic location. Similar to DSBs induced by zinc finger nucleases (ZFNs), the cell then activates endogenous DNA repair processes, either non-homologous end joining (NHEJ) or homology-directed repair (HDR), to heal the targeted DSB.
CAS9 plays a vital role in plasmid DNA interference. It is the only cas protein needed to deliver resistance against foreign DNA. CAS9 stimulates both RNA-guided genome editing and gene regulation in various organisms, but it can facilitate only one activity at a time within any given cell.

Features and Benefits

  • Highly specific
  • Highly active
  • Ready-to-inject/transfect

Packaging

pkg of 50 μg (≥ 300 pmol)
pkg of 250 μg (≥ 1500 pmol)

Preparation Note

Lyophilized S. pyogenes Cas9 protein should be resuspended in the Reconstitution solution provided to desired concentration. Gently tap tube to completely dissolve lyophilized powder, incubate for 10 minutes on ice, and spin tube to bring material to bottom of tube.

Other Notes

Each kit consists of:
  • one vial of Cas9 recombinant protein
  • one vial containing 1 mL of 1× dilution buffer
  • one vial containing 1 mL of nuclease-free water with glycerol
Use our CRISPR Selection Tool to order gRNA

Check out our other MISSION® Cas9 Proteins at SigmaAldrich.com/CRISPRproteins

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
CAS9PLESPCAS9PROCAS9GFPPRO
assay

≥95% (SDS-PAGE)

assay

≥95% (SDS-PAGE)

assay

≥95% (SDS-PAGE)

assay

≥90% (SDS-PAGE)

recombinant

expressed in E. coli

recombinant

expressed in E. coli

recombinant

expressed in E. coli

recombinant

expressed in E. coli

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

shipped in

wet ice

shipped in

wet ice

shipped in

ambient

shipped in

wet ice

packaging

pkg of 1 kit (3 components)

packaging

pkg of 1 kit (4 components)

packaging

pkg of 1 kit (3 components)

packaging

pkg of 1 kit (3 components)


Solo componentes del kit

Referencia del producto
Descripción

  • Cas9-NLS from Streptococcus pyogenes, expressed in Escherichia coli

  • Dilution buffer for Cas9 proteins

  • Reconstitution solution for Cas9 proteins

Clase de almacenamiento

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

wgk

WGK 3



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Preguntas

  1. potete condividere la sequenza della protein cas9

    1 respuesta
    1. The CAS9PROT sequence is based on Streptococcus pyogenes Cas9 from UniProt Q99ZW2 (1,368 aa). For CAS9PROT, N- and C-terminal linkers plus a single C-terminal nucleoplasmin NLS (KRPAATKKAGQAKKKK) are added, yielding a final sequence of 1,388 aa (~160 kDa). The full amino acid sequence corresponds to UniProt Q99ZW2 with the noted C-terminal additions. Please see the link below to review the UniProt sequence:
      https://www.uniprot.org/uniprotkb/Q99ZW2/entry#sequences

      ¿Le ha resultado útil?

Revisiones

Sin puntuación

Filtros activos